Neobiotech Global (South Korea) has no DMF, CEP or site registration linked in our records. 8 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Neobiotech Global: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/neobiotech-global

Overview

Neobiotech Global is a medical device company headquartered in Wŏnju, South Korea.

FDA compliance signals

8 FDA enforcement records linked to this company.

  • 4832019-05-13

    Strict control not exercised over labeling issued

  • 4832019-05-13

    Equipment Design, Size and Location

  • 4832019-05-13

    Absence of Written Procedures

  • 4832019-05-13

    Prepared for each batch, include complete information

  • 4832019-05-13

    Testing and release for distribution

  • 4832019-05-13

    Procedures To Be in Writing

  • 4832019-05-13

    Procedures to be written and followed

  • 4832019-05-13

    Lack of quality control unit

For suppliers

Is this Neobiotech Global?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.